Syntax Research’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.8K Hold
67
0.02% 111
2026
Q1
$18.1K Hold
67
0.01% 127
2025
Q4
$22.1K Hold
67
0.01% 118
2025
Q3
$23.1K Hold
67
0.01% 116
2025
Q2
$20.9K Hold
67
0.01% 113
2025
Q1
$35.1K Sell
67
-4
-6% -$2.04K 0.02% 96
2024
Q4
$35.9K Hold
71
0.03% 98
2024
Q3
$41.5K Buy
71
+4
+6% +$2.26K 0.03% 97
2024
Q2
$34.1K Hold
67
0.03% 95
2024
Q1
$33.1K Hold
67
0.03% 100
2023
Q4
$35.3K Sell
67
-6
-8% -$3.2K 0.03% 97
2023
Q3
$36.8K Buy
+73
New +$35.9K 0.03% 102

Other funds holding UNH

Syntax Research's UNH Position: Q2 2026 in Review

Syntax Research held its UnitedHealth (UNH) position steady in Q2 2026 at 67 shares worth $27.8K. The position accounts for 0.02% of the portfolio, ranked #111.

Syntax Research first reported a position in UNH in Q3 2023 and has held it in 12 quarters since. The position peaked at $41.5K in Q3 2024. 3,367 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Syntax Research held 67 shares of UnitedHealth worth $27.8K as of Q2 2026.
  • Syntax Research left its UnitedHealth share count unchanged in Q2 2026.
  • UnitedHealth made up 0.02% of Syntax Research's portfolio in Q2 2026, its #111 holding.
  • Syntax Research first reported a position in UnitedHealth in Q3 2023 and has held it in 12 quarters since.
  • Syntax Research's UnitedHealth position peaked at $41.5K in Q3 2024.
  • 3,367 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.